Oct 05, 2021 / 05:00PM GMT
Yevgeniya Livshits - Chardan Capital Markets, LLC, Research Division - Senior Research Analyst
Hello, and it's now my pleasure to introduce our next fireside chat guest, Dr. Stephen Hoge, President of Moderna. Stephen, thank you again for joining us today.
Questions and Answers:
Yevgeniya Livshits - Chardan Capital Markets, LLC, Research Division - Senior Research AnalystAnd maybe let's start off by big picture items. So last year, when you participated in our conference, Moderna was a Phase III company, and now millions of people have received the Moderna COVID-19 vaccine. We've seen the pipeline advance, and you've announced a number of research and manufacturing initiatives. So before we talk about these topics in a bit more detail, can you comment at a high level on Moderna's trajectory and priorities going forward?
Stephen Hoge - Moderna, Inc. - President
Well, thank you, and thanks again for having me back. I enjoyed it so much last year and the year before. So this will be an exciting chance to reprise
Trustpilot
